Veterinarians: Get your copy of our 24 page white paper today, covering Treatment of Joint Lameness, Pathophysiology, Manufacturing, Mechanism of Action, Clinical Safety and Putting it into Practice.
Clinical Studies
Discover multiple studies on ArthramidVet® 2.5% iPAAG
ArthramidVet® is used by veterinarians everyday around the world for the treatment of joint lameness in horses. Multiple published studies from high profile institutions, and treating thousands of equine patients across all equestrian disciplines, show that ArthramidVet® is a safe and effective treatment for osteoarthritis and joint lameness in animals.
Arthramid Vet White Paper
Get The White Paper
Clinical Studies
de Clifford, L.D., Lowe, J.N., McKellar, C.D., Bolwell, C., and David, F. (2021). A double-blinded positive control study comparing the relative efficacy of 2.5% polyacrylamide hydrogel (PAAG) against triamcinolone acetonide (TA) and sodium hyaluronate (HA) in the management of middle carpal joint lameness in racing Thoroughbreds.
Henrikson, M., Overgaard, A., and Bliddal, H. (2017). Initial Estimates of Efficacy of Intra-Articular 2.5% Polyacrylamide Hydrogel for the Treatment of Knee Osteoarthritis: An Observational Proof-of-Concept Study
Bathe, A.P., Read, R.M., and Briggs, C. (2016). Intra-articular polyacrylamide hydrogel for the treatment of 20 horses with non-responsive osteoarthritis of the interphalangeal joints: a prospective study
Christensen, L., Illigen, K.E., Hansen, M., Sarvaa, R., and Conogham, P.G. (2016). Synovial incorporation of polyacrylamide hydrogel after injection into normal and osteoarthritic animal joints
de Clifford, L.D., Lowe, J.N., McKellar, C.D., Bolwell, C., and David, F. (2019). Use of a 2.5% Cross-Linked Polyacrylamide Hydrogel in the Management of Joint Lameness in a Population of Flat Racing Thoroughbreds: A Pilot Study
de Clifford, L.D., Lowe, J.N., McKellar, C.D., Bolwell, C., and David, F. (2021). A double-blinded positive control study comparing the relative efficacy of 2.5% polyacrylamide hydrogel (PAAG) against triamcinolone acetonide (TA) and sodium hyaluronate (HA) in the management of middle carpal joint lameness in racing Thoroughbreds.
Testimonials
Dr Marcus Allan
TAURANGA VETERINARY SERVICES LTD
– NEW ZEALAND
– NEW ZEALAND
"Arthramid has been a great option for horse owners of all levels to provide effective osteoarthritis management.”
READ MORE
Dr Marcus Allan
TAURANGA VETERINARY SERVICES LTD
– NEW ZEALAND
– NEW ZEALAND
I manage horses that compete in a variety of disciplines and with the owner abilities ranging from novice to professional. As such, owner expectations vary markedly for managing the joint disease their horse may have. For example, cases of osteoarthritis typically seen can be early onset or be chronic in nature, and ranging from mild to severe. Patient age can be as young as 3 to over 20, and suffering from other disease processes such as endocrine issues. Managing client expectations is a challenge and an art. Finding the best solution for the client is the intended outcome and is not always easy to achieve.
Arthramid Vet enables me to effectively manage joints that have mild, moderate or severe osteoarthritic changes for a prolonged period of time and with very little chance of having an adverse reaction, even in those patients with other disease processes occurring concurrently. This provides peace of mind for the owner and myself. It also works out to be financially viable in the long-term. Arthramid has been a great option for horse owners of all levels to provide effective osteoarthritis management.
The longevity of effect and owner perception of arthramid not being a bioactive drug, are by far the biggest benefits. I would definitely recommend Arthramid Vet.
"Arthramid has been a great option for horse owners of all levels to provide effective osteoarthritis management.”
Dr Kim McKeller
AK & K EQUINE SERVICES
– VIC, AUSTRALIA
– VIC, AUSTRALIA
"I have now been using Arthramid Vet for years treating TB’s, SB’s and equestrian horses. It’s simply the best treatment we have for arthritis.”
READ MORE
Dr Kim McKeller
AK & K EQUINE SERVICES
– VIC, AUSTRALIA
– VIC, AUSTRALIA
I have been using Arthramid Vet for more than 5 years treating thoroughbreds, standardbreds and equestrian horses. 90 % of my work is lameness identification and treatment. I have injected over 600 joints with Arthramid Vet and I have experienced no side affects.
I have used all the alternative joint treatments over the last 50 years and consider Arthramid with or without triamcinolone superior to all other treatments. 85 % of my thoroughbred lameness localises to the intercarpal joint. If we are treating early cases before severe bone changes have occurred we will achieve long term reduction of joint inflammation. I have been using it as prophylactic in some stables. If we have major bone changes I add triamcinolone as required. I have used Arthramid Vet in Fetlocks, TMT, Coffin, Pastern and stifle joints.In the gliding joints it is a superb product with spectacular results. In my experience joint pain on flexion is gone in 2 weeks and usually lameness markedly reduced but the maximum result is not achieved for 6 weeks. In summary Arthramid Vet is a very valuable treatment option and is my first port of call for all lamenesses involving non septic joint inflammation
"I have now been using Arthramid Vet for years treating TB’s, SB’s and equestrian horses. It’s simply the best treatment we have for arthritis.”
Interested in talking to us
and learning more?
Send us a message and we will get in touch
Contact ArthramidVet
